Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Next-generation sequencing to characterize pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries
Avtorji:ID Sodja, Eva, Klinika Golnik (Avtor)
ID Koren, Simon (Avtor)
ID Toplak, Nataša (Avtor)
ID Truden, Sara, Klinika Golnik (Avtor)
ID Žolnir-Dovč, Marija, Klinika Golnik (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,53 MB)
MD5: 95947C58B237E922AB6302C82F389C72
 
URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S221371652100254X/pdfft?md5=fb191770c5ca327e3f1758114e724d42&pid=1-s2.0-S221371652100254X-main.pdf
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Objectives. Next-generation sequencing (NGS) provide a comprehensive analysis of the genetic alterations that are most commonly linked with pyrazinamide (PZA) resistance. There are no studies reporting molecular background of PZA resistance in TB isolates from Balkan Peninsula. We aimed to examine the feasibility of full-length analysis of a gene linked with PZA resistance, pncA, using Ion Torrent technology in comparison to phenotypic BACTEC MGIT 960 DST in clinical TB isolates from two countries of the Balkan Peninsula. Methods. Between 1996 and 2017, we retrospectively selected 61 TB isolates. To identify gene variants related to drug resistance in genomic DNA extracted from TB isolates, AmpliSeq libraries were generated automatically using the AmpliSeq™ Kit for Chef DL8 and the Ion AmpliSeq TB Research Panel. Result.s Of all 61 TB isolates included, 56 TB were phenotypically resistant to any antibiotic. Among them, 38/56 (67.9%) TB isolates were phenotypically resistant to pyrazinamide and pncA mutations were detected in 33/38 cases (86.8%). A mutation in the pncA promoter region was the most prevalent genetic alteration, detected in eight TB isolates. Comparison of NGS to conventional BACTEC MGIT 960 DST revealed very strong agreement (90.2%) between the two methods in identifying PZA resistance, with high sensitivity (89.5%) and specificity (95.7%) for NGS. Conclusions. Detection of PZA resistance using NGS seems to be a valuable tool for surveillance of TB drug resistance also in the Balkan Peninsula, with great potential to provide useful information at least one weak earlier than is possible with phenotypic DST.
Ključne besede:tuberculosis, Mycobacterium tuberculosis, high-throughput nucleotide sequencing, pyrazinamide, microbial sensitivity tests, next-generation sequencing, drug susceptibility testing, Slovenia, Republic of North Macedonia
Leto izida:2021
Status objave pri reviji:V tisku
Verzija članka:Postprint, avtorjeva končna recenzirana različica članka, sprejeta v objavo
Založnik:Elsevier on behalf of International Society for Antimicrobial Chemotherapy
Št. strani:str. 1-25
Številčenje:Vol.
Izvor:Nizozemska
UDK:616-002
ISSN pri članku:2213-7173
DOI:10.1016/j.jgar.2021.09.019 Novo okno
COBISS.SI-ID:89580803 Novo okno
Avtorske pravice:© 2021 The Authors
Opomba:Nasl. z nasl. zaslona; Soavtorji: Simon Koren, Nataša Toplak, Sara Truden, Manca Žolnir-Dovč; Opis vira z dne 15. 12. 2021;
Datum objave v DiRROS:10.01.2022
Število ogledov:321
Število prenosov:172
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
  
Objavi na:AddThis
AddThis uporablja piškotke, za katere potrebujemo vaše privoljenje.
Uredi privoljenje...

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Journal of global antimicrobial resistance
Založnik:Elsevier
ISSN:2213-7173
COBISS.SI-ID:56412419 Novo okno

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:21.11.2021

Sekundarni jezik

Jezik:Ni določen
Ključne besede:tuberkuloza, Mycobacterium tuberculosis, visokopretočno sekvenciranje, pirazinamid, test občutljivosti mikroorganizmov, sekvenciranje naslednje generacije, ugotavljanje občutljivosti za zdravila, Slovenija, Republika Severna Makedonija


Nazaj